<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01825967</url>
  </required_header>
  <id_info>
    <org_study_id>2013/532</org_study_id>
    <nct_id>NCT01825967</nct_id>
  </id_info>
  <brief_title>Acute Diverticulitis and C-Reactive Protein as a Prognostic Marker</brief_title>
  <official_title>Predictive Value of C-Reactive Protein in Acute Diverticulitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The management of acute diverticulitis maybe better if we have prognostic markers of
      evolution.

      Hypothesis: C-reactive protein maybe a good prognostic marker of evolution of acute
      diverticulitis.

      The investigators need to know the values of C-reactive protein to predict evolution of acute
      diverticulitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective observational study. All the patients with TC-diagnosis of acute diverticulitis
      (AD) had a C-reactive protein (PCR) in the initial blood test.

      The investigators will predict evolution of AD with the PCR initial.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>30 Days</target_duration>
  <primary_outcome>
    <measure>C-Reactive Protein</measure>
    <time_frame>24 Hours</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Acute Diverticulitis</condition>
  <arm_group>
    <arm_group_label>Acute Diverticulitis</arm_group_label>
    <description>We measured C-reactive protein in all the patients diagnosed with acute diverticulitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>C-reactive protein</intervention_name>
    <description>measured C-reactive protein in all patients with acute diverticulitis</description>
    <arm_group_label>Acute Diverticulitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All Patients with Acute Diverticulitis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute Diverticulitis

        Exclusion Criteria:

          -  Other Abdominal Pathologies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MORA LAURA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Corporacion Parc Tauli</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MORA L. LAURA, MD</last_name>
    <phone>34639101033</phone>
    <email>Lmora@tauli.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Corporacion Parc Tauli</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>34937231010</phone>
      <phone_ext>21490</phone_ext>
      <email>Lmora@tauli.cat</email>
    </contact>
    <contact_backup>
      <last_name>Laura Mora</last_name>
      <phone>3493723101033</phone>
      <phone_ext>21490</phone_ext>
      <email>Lmora@tauli.cat</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Corporacion parc tauli</name>
      <address>
        <city>Sabadell</city>
        <state>Sabadell-Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MORA L. LAURA, MD</last_name>
      <phone>34639101033</phone>
      <email>Lmora@tauli.cat</email>
    </contact>
    <investigator>
      <last_name>MORA L. LAURA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Corporacion Parc Tauli</name>
      <address>
        <city>Sabadell</city>
        <state>Sabadell/barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MORA L. LAURA, MD</last_name>
      <phone>34639101033</phone>
      <email>Lmora@tauli.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Corporacion Parc Tauli</name>
      <address>
        <city>Sabadell</city>
        <state>Sabadell/barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2013</study_first_submitted>
  <study_first_submitted_qc>April 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2013</study_first_posted>
  <last_update_submitted>April 9, 2013</last_update_submitted>
  <last_update_submitted_qc>April 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>LAURA MORA LOPEZ</investigator_full_name>
    <investigator_title>General Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diverticulitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

